A Pilot Trial of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Journal of Pancreatic Cancer
doi 10.1089/pancan.2019.0003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Implementation of Contemporary Chemotherapy for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Population-Based Analysis

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2020English

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients With Resectable Pancreatic Ductal Adenocarcinoma

HPB Surgery
SurgeryHepatology
2013English

Pancreatic Ductal Adenocarcinoma With Cystic Features

HPB
HepatologyGastroenterology
2016English

Switchable CAR-T Cells Mediate Remission in Metastatic Pancreatic Ductal Adenocarcinoma

Gut
Gastroenterology
2018English

Phase II Trial of Vatalanib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma After First-Line Gemcitabine Therapy (PCRT O4-001)

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2014English

Can Pharmacogenomics Guide Effective Anticancer Therapy in Pancreatic Ductal Adenocarcinoma?

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2012English

Contrast-Enhanced CT Radiomics for Predicting Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Pilot Study

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2020English

Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head With Venous Resection

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

Features of Immunophenotype of Pancreatic Ductal Adenocarcinoma

Zaporozhye Medical Journal
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy